Investigative Ophthalmology & Visual ScienceGeneticsPeer-reviewed journal article
Association between Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration
Johanna M. SeddoniD, James P. DossettiD, Rafael WidjajahakimiD, BERNARD A. ROSNERiD
Abstract
PURPOSETo determine associations between macular drusen parameters derived from an automatic optical coherence tomography (OCT) algorithm, age-related macular degeneration (AMD) stage and genetic variants.\n\nMETHODSEyes classified as early or intermediate AMD with OCT imaging and genetic data were selected (n=239 eyes). Drusen area and volume measurements were estimated using the Zeiss Cirrus advanced retinal pigment epithelium (RPE) analysis algorithm in a 5mm diameter (perifoveal) zone centered on the fovea. Associations between drusen measurements and common genetic variants in the complement and high density lipoprotein (HDL) lipid pathways and the ARMS2 variant were calculated using generalized estimating equations and linear mixed models adjusting for age, sex, smoking, BMI, and education.\n\nRESULTSWhen compared to eyes with no measurable drusen, drusen area [≥] the median was independently associated with a higher number of risk alleles for CFH risk score, risk variants in C3 and ARMS2/HTRA1. Similar results were obtained for drusen volume. When all genes were analyzed in the same model, only CFH score and ARMS2/HTRA1 were associated with drusen measurements. HDL pathway genes were not significantly related to drusen parameters. Early and intermediate AMD stages were associated with OCT derived drusen area and volume.\n\nCONCLUSIONGenetic variants in CFH and ARMS2/HTRA1, commonly associated with advanced AMD, were independently associated with higher drusen burden determined by OCT in eyes with early and intermediate AMD. The automatic RPE algorithm using OCT provides a quantitative classification of non-advanced AMD. Drusen morphology and other OCT-derived sub-phenotypes are biomarkers that could provide early anatomic endpoints for clinical trials.
- Citations
- 17
- FWCI
- 2.45
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic Risk of Reticular Pseudodrusen in Age-Related Macular Degeneration: HTRA1/lncRNA BX842242.1 dominates, with no evidence for Complement Cascade involvement
Samaneh Farashi, Carla J. Abbott, … Melanie Bahlo·Nature CommunicationsPeer-reviewed·Dec 8, 2025
- Novel protective associations with age-related macular degeneration: A common variant near CTRB1 and a rare variant in PELI3
Erin K. Wagner, Yi Yu, … Johanna M. Seddon·bioRxiv·Apr 9, 2016
- Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease
Thomas W. Winkler, Felix Graßmann, … Bernhard H. F. Weber·BMC Medical GenomicsPeer-reviewed·Aug 26, 2020
- Transcriptome-wide association implicates HTRA1-AS1 in age-related macular degeneration risk
Inti Anabela Pagnuco, Jacob Sampson, … Jamie M. Ellingford·medRxiv·Dec 7, 2025
- Genome-wide association study and genomic risk prediction of age-related macular degeneration in Israel
Michelle A. Grunin, Daria Triffon, … Itay Chowers·Scientific ReportsPeer-reviewed·Jun 6, 2024
- A Proteogenomic Signature of Age-related Macular Degeneration in Blood
Valur Emilsson, Elias Freyr Gudmundsson, … Tony E. Walshe·Nature CommunicationsPeer-reviewed·Jun 13, 2022